U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07462793) titled 'COntinuous Glucose Monitoring in nEwborns of Mothers With Insulin-Treated Gestational Diabetes Mellitus' on Feb. 27.

Brief Summary: The purpose of this study is to determine whether continuous glucose monitoring (CGM) improves the detection and management of neonatal hypoglycaemia in newborns of mothers with insulin-treated gestational diabetes.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Neonatal Hypoglycemia Gestational Diabetes Mellitus (GDM)

Intervention: DEVICE: Dexcom ONE Continuous Glucose Monitoring System

The Dexcom ONE continuous glucose monitoring system is applied to all participants. Foll...